iShares U.S. High Yield Fixed Income Index ETF (CAD-Hedged) (CHB): Price and Financial Metrics ETF
CHB Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $6.64 | 52-week high | $10.07 |
| Prev. close | $6.66 | 52-week low | $6.63 |
| Day low | $6.64 | Volume | 100 |
| Day high | $6.70 | Avg. volume | 712 |
| 50-day MA | $7.34 | Dividend yield | 0.59% |
| 200-day MA | $7.72 |
CHB Stock Price Chart Interactive Chart >
iShares U.S. High Yield Fixed Income Index ETF (CAD-Hedged) (CHB) ETF Bio
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index ("underlying index"). The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China's biotechnology industry. It is non-diversified.
CHB ETF Info
| Issuer | Global X Mgt |
| Expense Ratio | 0.65% |
| Underlying Index | Solactive China Biotech Innovation Index |
| Asset Class | Equity |
| Sector | Foreign Small/Mid Cap Blend Equities ETFs |
| Assets Under Management (AUM) | 1.39M |
| Net Asset Value (NAV) | $6.64 |
| Options? | Yes |
| Total Holdings | N/A |
CHB Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -14.85% |
| 3-year | -53.27% |
| 5-year | N/A |
| YTD | -18.02% |
| 2023 | -13.60% |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | N/A |
| 2019 | N/A |
CHB Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||